MedSci Sets 31 Aug 2026 Board Meeting to Review 1H26 Results and Potential Interim Dividend

Bulletin Express
Aug 19

MedSci Healthcare Holdings Limited has scheduled its next board meeting for 31 August 2026. Directors will review and approve the Group’s interim results for the six months ended 30 June 2026, decide on the publication of those results, and consider a possible interim dividend distribution.

The meeting agenda also allows for discussion of other routine corporate matters. The Board currently comprises eight members, including four executive directors—Dr. Zhang Fabao (Chairman), Dr. Li Xinmei, Mr. Wang Shuai and Mr. Cheng Liang—one non-executive director, Mr. Yan Shengfeng, and three independent non-executive directors, Ms. Liu Tao, Mr. Yu Mingyang and Mr. Lau Yiu Kwan Stanley.

The announcement was released in Hong Kong on 19 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10